Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,991 | 5,192 | 5,836 | 4,724 | 4,599 |
| Receivables | 21,917 | 17,091 | 20,183 | 20,743 | 20,240 |
| Inventories | 27,902 | 16,848 | 21,380 | 20,371 | 20,282 |
| Other current assets | 0 | 8,404 | 0 | 0 | 0 |
| TOTAL | $55,810 | $47,535 | $47,399 | $45,838 | $45,121 |
| Non-Current Assets | |||||
| PPE Net | 5,821 | 3,743 | 4,265 | 4,286 | 4,268 |
| Intangibles | 50,623 | 47,610 | 57,620 | 18,114 | 18,286 |
| Other Non-Current Assets | 58,693 | 10,466 | 1,394 | 40,621 | 39,721 |
| TOTAL | $115,137 | $61,819 | $63,279 | $63,021 | $62,275 |
| Total Assets | $170,947 | $109,354 | $110,678 | $108,859 | $107,396 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,413 | 2,765 | 2,765 | 2,779 | 2,722 |
| Accounts payable and accrued liabilities | 7,359 | 4,410 | 5,607 | 5,583 | 5,835 |
| Accrued Expenses | 8,227 | 4,211 | 4,690 | 3,860 | 4,423 |
| Other current liabilities | 1,432 | 2,150 | 252 | 471 | 478 |
| TOTAL | $22,284 | $14,041 | $13,947 | $13,239 | $14,056 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,569 | 8,983 | 9,674 | 10,417 | 10,931 |
| Deferred Revenues | 3,853 | 505 | 633 | 546 | 598 |
| Other Non-Current Liabilities | 6,098 | 2,777 | 3,528 | 3,433 | 3,234 |
| TOTAL | $69,369 | $14,413 | $19,826 | $20,408 | $20,625 |
| Total Liabilities | $91,653 | $28,454 | $33,773 | $33,647 | $34,681 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,980 | 35,595 | 34,881 | 34,835 | 34,619 |
| Common Shares | 422 | 419 | 418 | 418 | 418 |
| Retained earnings | -121,031 | -116,967 | -117,966 | -117,549 | -117,168 |
| Other shareholders' equity | -9,117 | -10,344 | -12,183 | -13,385 | -15,377 |
| TOTAL | $79,294 | $80,900 | $76,905 | $75,212 | $72,715 |
| Total Liabilities And Equity | $170,947 | $109,354 | $110,678 | $108,859 | $107,396 |